Cipla launches quality-assured Rectal Artesunate Suppositories for severe malaria in young children
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
Cipla Ltd, a global pharmaceutical company, and Medicines for Malaria Venture (MMV) announce the launch…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
Climate change has forced children and pregnant mothers to vary diets and skip meals, thus…
Four scientists — three of them in Africa — have won US$250,000 for combined success…
Johnson & Johnson announced the official launch of its global public health strategy at the…